Vimarsana
Biggest News Aggregation in the World

Page 50 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genentech Today - Breaking & Trending Today

FDA expands use of asthma drug Xolair to treat severe food allergies - Vimarsana News

FDA expands use of asthma drug Xolair to treat severe food allergies

A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call Transcript - Vimarsana News

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call Transcript

Jazz Pharmaceuticals plc misses on earnings expectations. Reported EPS is $5.02 EPS, expectations were $5.26.

John Snow Labs Announces Fourth Annual Healthcare NLP Summit Program Focused on Applied Generative AI - Vimarsana News

John Snow Labs Announces Fourth Annual Healthcare NLP Summit Program Focused on Applied Generative AI

Healthcare

New Musical 'Most Likely Not To' Aims To Put The Disability Community Center Stage - Vimarsana News

New Musical 'Most Likely Not To' Aims To Put The Disability Community Center Stage

In an interview with me earlier this week via videoconference, Genentech’s Adam Pryor explained the company became involved with the musical because they develop a med...

Source: forbes.com
Xolair asthma drug new hope for food allergies - Vimarsana News

Xolair asthma drug new hope for food allergies

Xolair receives FDA approval for severe food allergies. The researchers whose work led to the announcement claim it is a "game-changer" for allergy sufferers.

Source: bbc.com